Litcius/Paper detail

SARS-CoV-2 messenger RNA vaccine antibody response and reactogenicity in heart and lung transplant recipients

Andrew M. Hallett, Ross S. Greenberg, Brian J. Boyarsky, Pali D. Shah, Michael T. Ou, Aura T. Teles, Michelle R. Krach, Julia I. López, William A. Werbel, Robin K. Avery, Sunjae Bae, Aaron A.R. Tobian, Allan B. Massie, Robert Higgins, Jacqueline Garonzik‐Wang, Dorry L. Segev, Errol L. Bush

2021The Journal of Heart and Lung Transplantation65 citationsDOIOpen Access PDF

Topics & Concepts

MedicineReactogenicityVaccinationImmunologyAdverse effectPopulationInternal medicineBooster doseAntibodyImmunogenicityImmunizationEnvironmental healthSARS-CoV-2 and COVID-19 ResearchAnimal Virus Infections StudiesHeparin-Induced Thrombocytopenia and Thrombosis
SARS-CoV-2 messenger RNA vaccine antibody response and reactogenicity in heart and lung transplant recipients | Litcius